Breaking News Instant updates and real-time market news.

PX

Praxair

$146.21

1.61 (1.11%)

, LNEGY

Linde

$19.88

-0.02 (-0.10%)

12:31
04/12/18
04/12
12:31
04/12/18
12:31

Praxair, Linde pick second round bidders for divestitures, Reuters reports

Linde (LNEGY) and Praxair (PX) have picked second round bidders for a package of U.S. divestitures to facilitate their planned merger, Reuters reports, citing people close to the matter. The companies have invited CVC, Carlyle Group (CG), Onex and Blackstone (BX) to make further bids, sources told Reuters. Reference Link

PX

Praxair

$146.21

1.61 (1.11%)

LNEGY

Linde

$19.88

-0.02 (-0.10%)

CG

Carlyle Group

$20.50

-0.15 (-0.73%)

BX

Blackstone

$30.92

-0.0624 (-0.20%)

  • 12

    Apr

  • 19

    Apr

  • 19

    Apr

  • 26

    Apr

PX Praxair
$146.21

1.61 (1.11%)

03/27/18
BMOC
03/27/18
INITIATION
Target $159
BMOC
Market Perform
Praxair initiated with a Market Perform at BMO Capital
BMO Capital analyst John McNulty started Praxair with a Market Perform rating and $159 price target.
01/26/18
RHCO
01/26/18
NO CHANGE
Target $185
RHCO
Buy
Praxair price target raised to $185 from $165 at SunTrust
SunTrust analyst James Sheehan raised his price target on Praxair to $185 after Q4 earnings, citing accelerating volume growth in every end market and region as well as expectations of regulatory approval for Linde merger. Sheehan keeps his Buy rating on Praxair.
01/29/18
JPMS
01/29/18
DOWNGRADE
Target $170
JPMS
Neutral
Air Products downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jeffrey Zekauskas downgraded Air Products and Chemicals (APD) to Neutral while raising his price target for the shares to $170 from $168. At current valuation levels, the analyst prefers shares of Praxair (PX) in the industrial gas sector.
03/19/18
SBSH
03/19/18
NO CHANGE
SBSH
Buy
Praxair shares could fall 10%-15% initially if deal fails, says Citi
Citi analyst P.J. Juvekar believes Praxair (PX) shares could initially fall 10%-15% if the merger with Linde were to fail due to regulatory restrictions. The analyst, however, thinks shares should eventually trade based on its standalone merits, which he remains positive on. He recommends playing the deal through Praxair over Linde. Juvekar keeps a Buy rating on the shares.
LNEGY Linde
$19.88

-0.02 (-0.10%)

05/04/17
HSBC
05/04/17
UPGRADE
HSBC
Buy
Linde upgraded to Buy from Hold at HSBC
Price target EUR 179.
CG Carlyle Group
$20.50

-0.15 (-0.73%)

03/12/18
SBSH
03/12/18
UPGRADE
Target $28.5
SBSH
Buy
Carlyle Group upgraded to Buy from Neutral at Citi
Citi analyst William Katz upgraded Carlyle Group to Buy and raised his price target for the shares to $28.50 from $25. The analyst sees a higher FRE outlook and believes the recent pullback in shares enhances the risk adjusted return.
02/14/18
JEFF
02/14/18
UPGRADE
Target $27
JEFF
Buy
Carlyle Group upgraded to Buy from Hold at Jefferies
Jefferies analyst Gerald E. O'Hara upgraded Carlyle Group to Buy and raised his price target for the shares to $27 from $23. The analyst sees an attractive entry point for the shares with the company at the midway point of a $100B fundraising cycle. He believes Carlyle's net accrued performance fees are poised for continued growth with all main drawdown funds currently in carry contribution.
03/27/18
SBSH
03/27/18
NO CHANGE
SBSH
Citi says AkzoNobel free to think more strategically about M&A after divestiture
After AkzoNobel (AKZOY) announced the sale of its Specialty Chemicals business to Carlyle Group (CG) and GIC, Citi analyst P.J. Juvekar said the divestiture frees up the company to think more strategically about M&A. Akzo could go after Axalta (AXTA) again, but unless Akzo is prepared to pay a significant premium a deal is unlikely, said Juvekar. He thinks a price in the mid to high $30 range would be needed to get Axalta to the negotiating table. Akzo has thus far resisted a sale to PPG (PPG), but Juvekar thinks PPG would be interested if a deal were to be a friendly one.
03/12/18
03/12/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Time Warner (TWX) upgraded to Buy from Neutral at UBS with analyst John Hodulik saying while he expects the takeover by AT&T (T) to receive regulatory approval, he believes the current environment would make Time Warner's assets "highly attractive" to other media companies and Internet-based competitors were the deal to be blocked. 2. Carlyle Group (CG) and Apollo Global (APO) were upgraded to Buy from Neutral at Citi. 3. Merck (MRK) upgraded to Outperform from Market Perform at Leerink with analyst Seamus Fernandez saying Keytruda will continue to dominate the first-line non-small cell lung cancer market. 4. SAP (SAP) upgraded to Outperform from In Line at Evercore ISI with analyst Stewart Materne III saying that he believes the risk/reward is more attractive at current levels following the stock's 6% pullback. 5. Aratana Therapeutics (PETX) upgraded to Buy on valuation at CL King with the firm citing favorable risk/reward. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BX Blackstone
$30.92

-0.0624 (-0.20%)

01/31/18
MSCO
01/31/18
NO CHANGE
Target $40
MSCO
Overweight
Blackstone could be next disruptor, says Morgan Stanley
Following Blackstone's (BX) purchase of a 55% stake in Thomson Reuters' Financial and Risk business, Morgan Stanley analyst Michael Cyprys said Blackstone's deal signals the growing value in data and he sees opportunities for the asset manager to enhance its tool kit with big data and AI in order to bring transformational change to companies and industries. With nearly $100B in dry powder on which leverage can be applied, suggesting well over half trillion in spending power, Cyprys sees potential for Blackstone to act as a disruptor, he tells investors. The analyst keeps an Overweight rating and $40 price target on Blackstone shares.
03/20/18
DBAB
03/20/18
NO CHANGE
Target $126
DBAB
Buy
Celanese joint venture termination disappointing, says Deutsche Bank
Deutsche Bank analyst David Begleiter says the termination of Celanese's (CE) proposed acetate tow joint venture with Blackstone (BX) is disappointing, but not surprising. The odds of the combination being approved have been falling since October when the European Commission announced it had opened an in-depth investigation, Begleiter tells investors in a research note. The analyst lowered his price target for Celanese to $126 from $130 and keeps a Buy rating on the shares.
03/20/18
BARD
03/20/18
NO CHANGE
Target $130
BARD
Outperform
Baird reiterates Outperform rating on Celanese after tow JV terminated
Baird analyst Ghansham Panjabi reiterated his Outperform rating on Celanese (CE) following news that the company's joint venture with Blackstone's (BX) Rhodia Acetow business was terminated. In a research note to investors, Panjabi said that while the tow JV termination is "disappointing" and could weigh on shares, his long-term thesis is intact, as this outcome is "not overly surprising" given the extended timeline of the regulatory approvals process with the European Commission. He believes Celanese's management will remain "active" in its efforts to optimize the portfolio. The analyst has a $130 price target on shares.
03/27/18
RAJA
03/27/18
INITIATION
RAJA
Market Perform
Blackstone initiated with a Market Perform at Raymond James

TODAY'S FREE FLY STORIES

FB

Facebook

$143.17

-1.08 (-0.75%)

13:58
11/15/18
11/15
13:58
11/15/18
13:58
Hot Stocks
Facebook board admits to pushing CEO, COO to 'move faster' on interference »

The board of Facebook…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

SPY

SPDR S&P 500 ETF Trust

$271.90

1.71 (0.63%)

, SPX

S&P 500

$0.00

(0.00%)

13:57
11/15/18
11/15
13:57
11/15/18
13:57
Periodicals
U.S., China step up effort to strike G20 truce on trade, FT reports »

The U.S. and China have…

SPY

SPDR S&P 500 ETF Trust

$271.90

1.71 (0.63%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:55
11/15/18
11/15
13:55
11/15/18
13:55
General news
U.S. equities snapped back into the green »

U.S. equities snapped…

IAC

IAC

$180.83

0.23 (0.13%)

13:50
11/15/18
11/15
13:50
11/15/18
13:50
Hot Stocks
Rock Holdings acquires Dictionary.com, Thesaurus.com from IAC »

Dan Gilbert's Rock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLR

Fluor

$46.20

1.49 (3.33%)

13:48
11/15/18
11/15
13:48
11/15/18
13:48
Conference/Events
Fluor to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

RCMT

RCM Technologies

$4.03

0.03 (0.75%)

13:48
11/15/18
11/15
13:48
11/15/18
13:48
Hot Stocks
RCM Technologies announces acquisition of Thermal Kinetics, terms not disclosed »

RCM Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARE

Ultragenyx

$51.33

2.92 (6.03%)

13:45
11/15/18
11/15
13:45
11/15/18
13:45
Conference/Events
Ultragenyx haqs a conference call hosted by JPMorgan »

JPMorgan Analyst Kasimov…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 27

    Nov

  • 27

    Nov

VIAB

Viacom

$31.87

0.07 (0.22%)

, VIA

Viacom

$35.23

-0.1 (-0.28%)

13:41
11/15/18
11/15
13:41
11/15/18
13:41
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

VIAB

Viacom

$31.87

0.07 (0.22%)

VIA

Viacom

$35.23

-0.1 (-0.28%)

HP

Helmerich & Payne

$59.45

1.15 (1.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 16

    Nov

  • 16

    Nov

  • 04

    Dec

NVDA

Nvidia

$201.85

4.63 (2.35%)

, AMAT

Applied Materials

$34.94

1.35 (4.02%)

13:41
11/15/18
11/15
13:41
11/15/18
13:41
Earnings
Notable companies reporting after market close »

Notable companies…

NVDA

Nvidia

$201.85

4.63 (2.35%)

AMAT

Applied Materials

$34.94

1.35 (4.02%)

POST

Post Holdings

$91.15

-0.43 (-0.47%)

WSM

Williams-Sonoma

$60.67

-1.09 (-1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 16

    Nov

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

PPL

PPL Corp.

$30.56

-1.63 (-5.06%)

13:35
11/15/18
11/15
13:35
11/15/18
13:35
Options
PPL Corp. put volume heavy and directionally bearish »

Bearish flow noted in PPL…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$19.07

-6.59 (-25.68%)

13:32
11/15/18
11/15
13:32
11/15/18
13:32
Recommendations
PG&E analyst commentary  »

PG&E recent weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSGN

MSG Networks

$25.48

-0.53 (-2.04%)

13:20
11/15/18
11/15
13:20
11/15/18
13:20
Hot Stocks
MSG Networks announces sponsorship deal for Devils broadcasts with William Hill »

MSG Networks and William…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:20
11/15/18
11/15
13:20
11/15/18
13:20
General news
Atlanta Fed's Q4 GDPNow estimate was trimmed to 2.8% »

Atlanta Fed's Q4…

CVS

CVS Health

$79.23

-0.69 (-0.86%)

, AET

Aetna

$207.58

-0.58 (-0.28%)

13:17
11/15/18
11/15
13:17
11/15/18
13:17
Hot Stocks
California regulator approves CVS's acquisition of Aetna »

The California Department…

CVS

CVS Health

$79.23

-0.69 (-0.86%)

AET

Aetna

$207.58

-0.58 (-0.28%)

WCG

WellCare

$246.88

-4.14 (-1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/15/18
11/15
13:17
11/15/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCO

Clear Channel Outdoor

$5.51

0.19 (3.57%)

, OUT

Outfront Media

$21.01

0.32 (1.55%)

13:16
11/15/18
11/15
13:16
11/15/18
13:16
Periodicals
Clear Channel Outdoor rises after JCDecaux CEO expresses takeover interest »

JCDecaux (JCDXF) CEO…

CCO

Clear Channel Outdoor

$5.51

0.19 (3.57%)

OUT

Outfront Media

$21.01

0.32 (1.55%)

JCDXF

JCDecaux

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/15/18
11/15
13:16
11/15/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
11/15/18
11/15
13:15
11/15/18
13:15
General news
Atlanta Fed dove Bostic wants to "proceed cautiously" »

Atlanta Fed dove Bostic…

FB

Facebook

$142.11

-2.14 (-1.48%)

13:12
11/15/18
11/15
13:12
11/15/18
13:12
Hot Stocks
Facebook comments on progress enforcing community standards »

Facebook comments on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

CCO

Clear Channel Outdoor

$5.21

-0.11 (-2.07%)

, OUT

Outfront Media

$20.64

-0.05 (-0.24%)

13:11
11/15/18
11/15
13:11
11/15/18
13:11
Periodicals
Breaking Periodicals news story on Clear Channel Outdoor, Outfront Media »

JCDecaux has expressed…

CCO

Clear Channel Outdoor

$5.21

-0.11 (-2.07%)

OUT

Outfront Media

$20.64

-0.05 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

NICE

Nice Systems

$110.77

0.48 (0.44%)

13:11
11/15/18
11/15
13:11
11/15/18
13:11
Conference/Events
Nice Systems management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

UNIT

Uniti Group

$18.54

-0.68 (-3.54%)

13:10
11/15/18
11/15
13:10
11/15/18
13:10
Options
Second day of put buying in Uniti Group as shares display relative weakness »

Second day of put buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$18.11

2 (12.41%)

13:05
11/15/18
11/15
13:05
11/15/18
13:05
Options
Amarin call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYB

RYB Education

$7.51

-9.3 (-55.32%)

, BEDU

Bright Scholar

$10.34

-2.435 (-19.07%)

13:02
11/15/18
11/15
13:02
11/15/18
13:02
Hot Stocks
RYB, Bright Scholar slide on new Chinese stock policy for private kindergartens »

Shares of RYB Education…

RYB

RYB Education

$7.51

-9.3 (-55.32%)

BEDU

Bright Scholar

$10.34

-2.435 (-19.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 16

    Nov

AVEO

Aveo Pharmaceuticals

$1.86

-0.04 (-2.11%)

13:01
11/15/18
11/15
13:01
11/15/18
13:01
Recommendations
Aveo Pharmaceuticals analyst commentary  »

Piper Jaffray sees FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.